Dopamine-2 Receptor Antagonist
32 drugs across 13 manufacturers|32 Generic,0 Brand
The Dopamine-2 Receptor Antagonist class contains 32 NDCs from 13 manufacturers (32 generic, 0 brand), at an average NADAC of $0.16 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
32
32G / 0B
Manufacturers
13
Avg $0.1580/unit
Avg 7d Change
-0.36%
Across 24 drugs with changes
7d Activity
of 32 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
13 manufacturers producing drugs in this therapeutic class
and 1 more manufacturer
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Metoclopramide market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Dopamine-2 Receptor Antagonist class?
The Dopamine-2 Receptor Antagonist class contains 32 NDCs from 13 manufacturers — 32 generic and 0 brand products.
What is the average price of Dopamine-2 Receptor Antagonist drugs?
The average NADAC for the Dopamine-2 Receptor Antagonist class is $0.1580 per unit across 32 NDCs.
Which manufacturers make Dopamine-2 Receptor Antagonist drugs?
13 manufacturers make drugs in the Dopamine-2 Receptor Antagonist class. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (5), ScieGen Pharmaceuticals, Inc. (5), Ipca Laboratories Limited (5), Hospira Inc. (4), ANI Pharmaceuticals, Inc. (3).
How has Dopamine-2 Receptor Antagonist pricing changed recently?
Over the past 7 days, 21 NDCs in this class rose and 3 fell, with a class-wide average change of -0.4%.